@article{article, title  = {{Correlative analyses of plasma cytokine/angiogenic factor (C/AF) profile, gender and outcome in a randomized, three-arm, phase II trial of first-line vandetanib (VAN) and/or carboplatin plus paclitaxel (CP) for advanced non-small cell lung cancer (NSCLC)}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{}},

 year = {{2007}},

 month = {{6}},

 author = {{Hanrahan EO and Lin HY and Du DZ and Yan S and Kim ES and Lee JJ and Ryan AJ and Tran HT and Johnson BE and Heymach JV}},

 doi = {{10.1200/jco.2007.25.18_suppl.7593}},

 volume = {{25}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{18_suppl}},

 pages = {{7593-7593}},

 note = {{Accessed on 2026/03/02}}}